Newfound Research’s Seagen Inc. Common Stock SGEN Stock Holding History

Newfound Research’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$42K	Sell	306 -421	-58%	-$68.6K	0.1%	124
2022 Q2	$129K	Sell	727 -303	-29%	-$43.7K	0.27%	21
2022 Q1	$148K	Buy	1,030 +141	+16%	+$19.1K	0.19%	40
2021 Q4	$137K	Buy	889 +126	+17%	+$21.1K	0.17%	63
2021 Q3	$130K	Buy	763 +208	+37%	+$32.4K	0.21%	13
2021 Q2	$88K	Buy	555 +219	+65%	+$32.5K	0.17%	54
2021 Q1	$47K	Buy	+336	New	+$54.1K	0.11%	109
2020 Q4	–	Sell	-174	Closed	-$34K	–	169
2020 Q3	$34K	Buy	+174	New	+$29.1K	0.1%	63

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newfound Research's SGEN Position: Q3 2022 in Review

Newfound Research reduced its Seagen Inc. Common Stock (SGEN) stake by 58% in Q3 2022, selling an estimated $68.6K and leaving 306 shares worth $42K. The position accounts for 0.1% of the portfolio, ranked #124.

Newfound Research first reported a position in SGEN in Q3 2020 and has held it in 8 quarters since. The position peaked at $148K in Q1 2022. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

Newfound Research held 306 shares of Seagen Inc. Common Stock worth $42K as of Q3 2022.
Newfound Research sold 421 Seagen Inc. Common Stock shares in Q3 2022, an estimated $68.6K.
Seagen Inc. Common Stock made up 0.1% of Newfound Research's portfolio in Q3 2022, its #124 holding.
Newfound Research first reported a position in Seagen Inc. Common Stock in Q3 2020 and has held it in 8 quarters since.
Newfound Research's Seagen Inc. Common Stock position peaked at $148K in Q1 2022.
539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.